Eugia Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EUGIA PHARMA, and what generic alternatives to EUGIA PHARMA drugs are available?
EUGIA PHARMA has one hundred and seventy approved drugs.
There is one US patent protecting EUGIA PHARMA drugs. There are three tentative approvals on EUGIA PHARMA drugs.
There are ten patent family members on EUGIA PHARMA drugs in nine countries and three hundred and fifty-two supplementary protection certificates in eighteen countries.
Summary for Eugia Pharma
| International Patents: | 10 |
| US Patents: | 1 |
| Tradenames: | 144 |
| Ingredients: | 136 |
| NDAs: | 170 |
| Patent Litigation for Eugia Pharma: | See patent lawsuits for Eugia Pharma |
Drugs and US Patents for Eugia Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eugia Pharma | MEDROXYPROGESTERONE ACETATE | medroxyprogesterone acetate | INJECTABLE;INJECTION | 212844-001 | Aug 31, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Eugia Pharma | MILRINONE LACTATE IN DEXTROSE 5% | milrinone lactate | INJECTABLE;INJECTION | 209666-001 | Sep 3, 2020 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Eugia Pharma | LENALIDOMIDE | lenalidomide | CAPSULE;ORAL | 213885-006 | Mar 6, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Eugia Pharma | ALCAFTADINE | alcaftadine | SOLUTION/DROPS;OPHTHALMIC | 210659-001 | Jun 23, 2023 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Eugia Pharma | ESOMEPRAZOLE SODIUM | esomeprazole sodium | INJECTABLE;INTRAVENOUS | 204657-001 | Aug 10, 2016 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Eugia Pharma Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 106456654 | ⤷ Subscribe |
| World Intellectual Property Organization (WIPO) | 2015171460 | ⤷ Subscribe |
| Brazil | 112016026140 | ⤷ Subscribe |
| Russian Federation | 2016147362 | ⤷ Subscribe |
| Japan | 6516831 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Eugia Pharma Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 3043773 | SPC/GB21/077 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: MOMETASONE OR A SALT THEREOF AND OLOPATADINE OR A SALT THEREOF; REGISTERED: AT 140638 20210426; UK PL 25258/0331 - 0001 20210511 |
| 0806968 | SPC/GB07/011 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: GADOFOSVESET TRISODIUM; REGISTERED: UK EU/1/05/313/001 20051003; UK EU/1/05/313/002 20051003; UK EU/1/05/313/003 20051003; UK EU/1/05/313/004 20051003; UK EU/1/05/313/005 20051003; UK EU/1/05/313/006 20051003; UK EU/1/05/313/007 20051003; UK EU/1/05/313/008 20051003; UK EU/1/05/313/009 20051003 |
| 1411918 | PA2012011 | Lithuania | ⤷ Subscribe | PRODUCT NAME: PLERIXAFORUM; REGISTRATION NO/DATE: EU/1/09/537/001 20090731 |
| 1746976 | SPC/GB17/043 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: IRINOTECAN SUCROSOFATE SALT; REGISTERED: UK EU/1/16/1130 20161018 |
| 0788360 | SPC/GB04/021 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: BORTEZOMIB OR PHARMACEUTICALLY ACCEPTABLE ESTER THEREOF, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK EU/1/04/274/001 20040428 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
